Clinical Trials Directory

Trials / Completed

CompletedNCT00617084

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent

RESOLUTE-III All-comers Trial: A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
2,292 (actual)
Sponsor
Medtronic Vascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The RESOLUTE-III Allcomers trial is a prospective, multicenter, randomized, two-arm, international, non-inferiority, open-label study with 2300 patients at 15-20 centers. The study is a "real world, all comers" study. Primary objective: to compare the Medtronic Endeavor-Resolute (Zotarolimus-Eluting stent) system with the Abbott XIENCE V (Everolimus-Eluting stent) system with respect to cardiac death, myocardial infarction (not clearly attributable to a non-target vessel), Target Lesion Revascularization at 1 year in a "real world" patient population.

Detailed description

The RESOLUTE-III Allcomers trial is a prospective, multicenter, randomized, two-arm, international, non-inferiority, open-label study with 2300 patients at 15-20 centers. The study is a "real world, all comers" study. Primary objective: to compare the Medtronic Endeavor-Resolute (Zotarolimus-Eluting stent) system with the Abbott XIENCE V (Everolimus-Eluting stent) system with respect to cardiac death, myocardial infarction (not clearly attributable to a non-target vessel), Target Lesion Revascularization at 1 year in a "real world" patient population. Study hypothesis: To determine whether the Zotarolimus-Eluting stent (Medtronic Endeavor-Resolute) is non-inferior to the Everolimus-eluting stent (Abbott XIENCE V) in terms of the primary endpoint at 12 months after stent implantation.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic Endeavor ResoluteMedtronic Endeavor Resolute
DEVICEAbbott Xience VAbbott Xience V

Timeline

Start date
2008-04-01
Primary completion
2010-05-01
Completion
2014-02-01
First posted
2008-02-15
Last updated
2014-06-06
Results posted
2011-05-17

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00617084. Inclusion in this directory is not an endorsement.